188 related articles for article (PubMed ID: 24946857)
1. Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas.
Adachi-Hayama M; Adachi A; Shinozaki N; Matsutani T; Hiwasa T; Takiguchi M; Saeki N; Iwadate Y
BMC Cancer; 2014 Jun; 14():452. PubMed ID: 24946857
[TBL] [Abstract][Full Text] [Related]
2. Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.
Matsutani T; Hiwasa T; Takiguchi M; Oide T; Kunimatsu M; Saeki N; Iwadate Y
J Exp Clin Cancer Res; 2012 Oct; 31(1):85. PubMed ID: 23050879
[TBL] [Abstract][Full Text] [Related]
3. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.
Ortiz-Genga MF; Cuenca S; Dal Ferro M; Zorio E; Salgado-Aranda R; Climent V; Padrón-Barthe L; Duro-Aguado I; Jiménez-Jáimez J; Hidalgo-Olivares VM; García-Campo E; Lanzillo C; Suárez-Mier MP; Yonath H; Marcos-Alonso S; Ochoa JP; Santomé JL; García-Giustiniani D; Rodríguez-Garrido JL; Domínguez F; Merlo M; Palomino J; Peña ML; Trujillo JP; Martín-Vila A; Stolfo D; Molina P; Lara-Pezzi E; Calvo-Iglesias FE; Nof E; Calò L; Barriales-Villa R; Gimeno-Blanes JR; Arad M; García-Pavía P; Monserrat L
J Am Coll Cardiol; 2016 Dec; 68(22):2440-2451. PubMed ID: 27908349
[TBL] [Abstract][Full Text] [Related]
4. Serum GFAP autoantibody as an ELISA-detectable glioma marker.
Wei P; Zhang W; Yang LS; Zhang HS; Xu XE; Jiang YH; Huang FP; Shi Q
Tumour Biol; 2013 Aug; 34(4):2283-92. PubMed ID: 23589055
[TBL] [Abstract][Full Text] [Related]
5. LGI1 tumor tissue expression and serum autoantibodies in patients with primary malignant glioma.
Dazzo E; Pasini E; Furlan S; de Biase D; Martinoni M; Michelucci R; Nobile C;
Clin Neurol Neurosurg; 2018 Jul; 170():27-33. PubMed ID: 29723732
[TBL] [Abstract][Full Text] [Related]
6. Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias.
Ohiri JC; Dellefave-Castillo L; Tomar G; Wilsbacher L; Choudhury L; Barefield DY; Fullenkamp D; Gacita AM; Monroe TO; Pesce L; Blancard M; Vaught L; George AL; Demonbreun AR; Puckelwartz MJ; McNally EM
J Am Heart Assoc; 2024 May; 13(10):e030467. PubMed ID: 38761081
[TBL] [Abstract][Full Text] [Related]
7. MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients.
Wu H; Deng Z; Wang H; Li X; Sun T; Tao Z; Yao L; Jin Y; Wang X; Yang L; Ma H; Huang Y; Zhou Y; Du Z
Cancer Med; 2019 Aug; 8(9):4359-4369. PubMed ID: 31210005
[TBL] [Abstract][Full Text] [Related]
8. Filamin C in cardiomyopathy: from physiological roles to DNA variants.
Song S; Shi A; Lian H; Hu S; Nie Y
Heart Fail Rev; 2022 Jul; 27(4):1373-1385. PubMed ID: 34535832
[TBL] [Abstract][Full Text] [Related]
9. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.
Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY
Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458
[TBL] [Abstract][Full Text] [Related]
11. Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas.
Huang Q; Wang C; Hou Z; Wang G; Lv J; Wang H; Yang J; Zhang Z; Zhang H
Cancer Biomark; 2017; 19(2):137-144. PubMed ID: 28211798
[TBL] [Abstract][Full Text] [Related]
12. Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.
Janssens J; Philtjens S; Kleinberger G; Van Mossevelde S; van der Zee J; Cacace R; Engelborghs S; Sieben A; Banzhaf-Strathmann J; Dillen L; Merlin C; Cuijt I; Robberecht C; Schmid B; Santens P; Ivanoiu A; Vandenbulcke M; Vandenberghe R; Cras P; De Deyn PP; Martin JJ; Maudsley S; Haass C; Cruts M; Van Broeckhoven C;
Acta Neuropathol Commun; 2015 Nov; 3():68. PubMed ID: 26555887
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
[TBL] [Abstract][Full Text] [Related]
14. Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer.
Qiu C; Duan Y; Wang B; Shi J; Wang P; Ye H; Dai L; Zhang J; Wang X
Front Immunol; 2021; 12():698312. PubMed ID: 34489945
[TBL] [Abstract][Full Text] [Related]
15. BMI-1 autoantibody as a new potential biomarker for cervical carcinoma.
Tong YQ; Liu B; Zheng HY; He YJ; Gu J; Li F; Li Y
PLoS One; 2011; 6(11):e27804. PubMed ID: 22132147
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of filamin c in chronic intermittent hypoxia-induced cardiomyocyte apoptosis is a potential cardioprotective target for obstructive sleep apnea.
Yang X; Shi Y; Zhang L; Liu H; Shao Y; Zhang S
Sleep Breath; 2019 Jun; 23(2):493-502. PubMed ID: 30194514
[TBL] [Abstract][Full Text] [Related]
17. Tracking tumor alteration in glioma through serum fibroblast activation protein combined with image.
Yang XS; Zhu P; Xie RX; Chen PF; Liu H; Cheng XM; Zhu ZQ; Peng XM; Liu HB; Yang QY; Li JQ; Zhang J
BMC Cancer; 2023 Oct; 23(1):1012. PubMed ID: 37864148
[TBL] [Abstract][Full Text] [Related]
18. CREB3L1 and PTN expressions correlate with prognosis of brain glioma patients.
Liu LQ; Feng LF; Nan CR; Zhao ZM
Biosci Rep; 2018 May; 38(3):. PubMed ID: 29531016
[TBL] [Abstract][Full Text] [Related]
19. Structure and Function of Filamin C in the Muscle Z-Disc.
Mao Z; Nakamura F
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295012
[TBL] [Abstract][Full Text] [Related]
20. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
